Literature DB >> 9515764

Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection.

T Höhler1, A Kruger, G Gerken, P M Schneider, K H Meyer zum Büschenfelde, C Rittner.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is involved in the pathogenesis of chronic hepatitis C virus infection. The gene for TNF-alpha is encoded in the major histocompatibility locus (MHC). Two polymorphisms at positions -308 and -238 in the TNF-alpha promoter region might influence TNF-alpha expression. These promoter polymorphisms have been linked previously to a number of infectious diseases. TNF-alpha promoter polymorphisms at positions -238 and -308 were studied by DNA sequencing and sequence-specific oligonucleotide hybridization in 82 individuals with chronic hepatitis C and 99 control subjects. Subjects had been HLA class I and class II typed in a previous study. The frequency of the TNF238.2 promoter allele was significantly higher in the hepatitis C group (18.7%) compared to the controls (3.5%; P < 0.0001; pcorr < 0.009). No significant differences in the frequency of the TNF308.2 allele were observed between patients and controls. The increased frequency of the TNF238.2 allele could not be explained by linkage disequilibrium to HLA-B or -DR genes. These findings show an association between the TNF238.2 promoter variant and chronic active hepatitis C. They suggest that this polymorphism or a linked gene may be a host factor contributing to the development of chronic active hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515764     DOI: 10.1002/(sici)1096-9071(199803)54:3<173::aid-jmv5>3.0.co;2-2

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.

Authors:  Gisela Barbisan; Luis Orlando Pérez; Anahí Contreras; Carlos Daniel Golijow
Journal:  Tumour Biol       Date:  2012-05-17

3.  Effects of the -791(C→T) mutation in the promoter for tumor necrosis factor alpha on gene expression and resistance of Large White pigs to enterotoxigenic Escherichia coli F18.

Authors:  Ying Liu; Chaohui Dai; Li Sun; Guoqiang Zhu; Shenglong Wu; Wenbin Bao
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

Review 4.  Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection.

Authors:  Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.

Authors:  Ankur Goyal; P V Suneetha; G T Kumar; Deepak K Shukla; Naveen Arora; Shiv K Sarin
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

6.  Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome.

Authors:  Julian Knight
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

7.  Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.

Authors:  Zaigham Abbas; Tariq Moatter; Akber Hussainy; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

8.  TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais.

Authors:  Sasijit Vejbaesya; Panpimon Luangtrakool; Komon Luangtrakool; Siripen Kalayanarooj; David W Vaughn; Timothy P Endy; Mammen P Mammen; Sharone Green; Daniel H Libraty; Francis A Ennis; Alan L Rothman; Henry A F Stephens
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

9.  Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.

Authors:  Jen-Eing Jeng; Jung-Fa Tsai; Lee-Yea Chuang; Mei-Shang Ho; Zu-Yau Lin; Min-Yuh Hsieh; Shin-Chern Chen; Wan-Lung Chuang; Liang-Yen Wang; Ming-Lung Yu; Chia-Yen Dai; Jan-Gowth Chang
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis.

Authors:  John R Ticehurst; Fayez M Hamzeh; David L Thomas
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.